- SG$2.48bn
- SG$2.04bn
- SG$232.06m
- 74
- 58
- 81
- 88
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.67 | ||
Price to Tang. Book | 0.67 | ||
Price to Free Cashflow | 44.92 | ||
Price to Sales | 10.39 | ||
EV to EBITDA | 26.91 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.6% | ||
Return on Equity | 6.61% | ||
Operating Margin | 102.07% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SG$m | 243.99 | 111.03 | 141.18 | 182.09 | 232.06 | n/a | n/a | -0.49% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +1.63 | -34.28 | -8.12 | +34.66 | +46 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing the Tiger trademarks and owning and holding investments for the long-term. Its segments include Healthcare products, Investments and Others. Its Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brands. Its Investments segment is engaged in long term investing activities, mainly in quoted securities in Asia. Its Others segment includes the property division, which owns and leases out several investment properties in Asia, and the leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand offers products such as Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch, and Tiger Balm Muscle Rub. Its Kwan Loong brand offers products such as Kwan Loong Medicated Oil and Kwan Loong Refresher.
Directors
- Cho Yaw Wee NEC (92)
- Ee Lim Wee CEO (59)
- Ee-Chao Wee NVC (66)
- Brian Loo GMG
- Say Suan Chow CTR (48)
- Li Chow Tang DHR
- Bee Leong Goh OTH
- Jasmin Hong OTH
- Chua Keeth OTH
- Mui Lick Kow OTH
- Wah Tong Ng OTH
- Siew Leng Shiu OTH
- Sung Tze Whang OTH
- Kay Swee Lee SEC (53)
- Choon Soo Chew NID (63)
- Hiang Meng Gn NID (73)
- Weng Keong Low NID (69)
- Sim Ho Ong NID (52)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- July 18th, 1969
- Public Since
- January 2nd, 1979
- No. of Shareholders
- 19,862
- No. of Employees
- 595
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 221,368,173
- Address
- 401 Commonwealth Drive, 149598
- Web
- https://www.hawpar.com/
- Phone
- +65 63379102
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for H02
Haw Par Corporation Ltd Annual Shareholders Meeting
Similar to H02
Hyphens Pharma International
Singapore Exchange Securities Trading Ltd
IX Biopharma
Singapore Exchange Securities Trading Ltd
Pharmesis International
Singapore Exchange Securities Trading Ltd
Suntar Eco-City
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 20:03 UTC, shares in Haw Par are trading at SG$11.22. This share price information is delayed by 15 minutes.
Shares in Haw Par last closed at SG$11.22 and the price had moved by +13.91% over the past 365 days. In terms of relative price strength the Haw Par share price has outperformed the FTSE Developed Asia Pacific Index by +7.24% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Haw Par dividend yield is 3.57% based on the trailing twelve month period.
Last year, Haw Par paid a total dividend of SG$0.40, and it currently has a trailing dividend yield of 3.57%. We do not have any data on when Haw Par is to next pay dividends.
We do not have data on when Haw Par is to next pay dividends. The historic dividend yield on Haw Par shares is currently 3.57%.
To buy shares in Haw Par you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$11.22, shares in Haw Par had a market capitalisation of SG$2.48bn.
Here are the trading details for Haw Par:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: H02
Based on an overall assessment of its quality, value and momentum Haw Par is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Haw Par is SG$17.00. That is 51.52% above the last closing price of SG$11.22.
Analysts covering Haw Par currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Haw Par. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +14.45%.
As of the last closing price of SG$11.22, shares in Haw Par were trading +9.84% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Haw Par PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$11.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Haw Par's management team is headed by:
- Cho Yaw Wee - NEC
- Ee Lim Wee - CEO
- Ee-Chao Wee - NVC
- Brian Loo - GMG
- Say Suan Chow - CTR
- Li Chow Tang - DHR
- Bee Leong Goh - OTH
- Jasmin Hong - OTH
- Chua Keeth - OTH
- Mui Lick Kow - OTH
- Wah Tong Ng - OTH
- Siew Leng Shiu - OTH
- Sung Tze Whang - OTH
- Kay Swee Lee - SEC
- Choon Soo Chew - NID
- Hiang Meng Gn - NID
- Weng Keong Low - NID
- Sim Ho Ong - NID